Novo Nordisk's Semaglutide tau pom zoo nyob rau hauv Suav teb rau Kev Tswj Kev Nyuaj Siab Ntev

Novo Nordisk's Semaglutide tau pom zoo nyob rau hauv Suav teb rau Kev Tswj Kev Nyuaj Siab Ntev

 

Thaum Lub Rau Hli 25th, cov neeg sau xov xwm los ntawm Phau Ntawv tau kawm los ntawm Novo Nordisk Tuam Tshoj tias tsis ntev los no, National Medical Products Administration (NMPA) tau pom zoo rau daim ntawv thov kev lag luam ntawm Novo Nordisk's Ozempic (semaglutide txhaj rau kev tswj qhov hnyav mus ntev) hauv Suav teb.

Novo Nordisk tau hais tias qhov no yog lub ntiaj teb thawj zaug thiab tam sim no tsuas yog glucagon-zoo li peptide -1 receptor agonist (GLP-1) txhua lub lim tiam rau kev tswj qhov hnyav, muaj peev xwm ua tiav qhov nruab nrab qhov hnyav ntawm 17. % (16.8 kg), thiab nqa ntau yam txiaj ntsig kev noj qab haus huv tshaj qhov poob phaus, nrog rau nws txoj kev nyab xeeb dav dav.

Cov kev pom zoo pom zoo yog rau cov neeg mob hnyav thiab rog, nrog qhov pib BMI ntawm 30 kg / m² lossis ntau dua; los yog nruab nrab ntawm 27 kg / m² thiab 30 kg / m², thiab nrog tsawg kawg yog ib qho hnyav-txog comorbidity, nrog rau ib zaug ib lub lim tiam.

Thaum ntxov li xyoo 1997, Lub Koom Haum Saib Xyuas Kev Noj Qab Haus Huv Ntiaj Teb (WHO) txhais tias kev rog rog yog ib yam kab mob. Hauv ob xyoos dhau los, GLP-1 cov tshuaj poob phaus tau nyiam thoob ntiaj teb, cov uas Novo Nordisk's semaglutide yog undoubtedly ib lub hnub qub khoom. Novo Nordisk daim ntawv tshaj tawm thawj peb lub hlis twg qhia tau hais tias qhov poob phaus version ntawm semaglutide, Wegovy, muaj kev muag khoom ntawm 9.377 billion Danish kroner, ib xyoos ib zaug nce ntawm 106%. Ntxiv nrog rau qhov qhia txog ntshav qab zib, semaglutide kuj tseem suav nrog kev lag luam raws li lub peev xwm "lub ntiaj teb cov tshuaj sab saum toj."

Yav dhau los, semaglutide twb tau pom zoo hauv Suav teb rau ntshav qab zib, raws li kev lag luam npe Ozempic. Ua ntej qhov kev pom zoo, qee cov neeg tau siv cov tshuaj tawm ntawm daim ntawv lo. Tam sim no nws tau raug pom zoo rau kev poob phaus hauv Suav teb, nws txhais tau hais tias cov neeg muaj peev xwm poob phaus tuaj yeem tau txais cov tshuaj los ntawm kev ua raws li txoj cai, uas tseem yuav tsum tau tsav lub ntiaj teb kev muag khoom ntawm semaglutide.

Lub active ingredient ntawm Ozempic yog semaglutide, thiab lub ntiaj teb no loj-scale soj ntsuam sim ntawm cov tshuaj no, STEP series, suav nrog txog 25, 000 rog rog thiab rog. Cov txiaj ntsig tau sim tau pom tias piv nrog cov placebo, kev kho Ozempic tau pom tias muaj txiaj ntsig zoo dua, muaj txiaj ntsig zoo hauv kev kho mob, thiab kev poob phaus, nrog qhov hnyav nruab nrab ntawm 17% (16.8 kg), uas tuaj yeem kav ntev li 16 lub hlis. Tsis tas li ntawd, Ozempic tuaj yeem nqa ntau yam txiaj ntsig kev noj qab haus huv tshaj qhov poob phaus. STEP series ntawm cov kev tshawb fawb pom tau hais tias Ozempic tuaj yeem txo lub duav ncig, txo cov roj visceral, txhim kho cov ntshav lipids, thiab ncua kev loj hlob ntawm prediabetes.

Raws li lub hauv paus chiv keeb tshuaj, Novo Nordisk's semaglutide tseem tab tom ntsib kev sib tw siab tom qab tas sij hawm ntawm patents. Cov ntaub ntawv pej xeem qhia tau hais tias patent rau Novo Nordisk's semaglutide yuav tas rau xyoo 2026. Thaum Lub Rau Hli 2021, Huadong Medicine's subsidiary, China-US Huadong, tau xa daim ntawv thov tsis raug cai rau cov tseem ceeb patent ntawm semaglutide rau National Intellectual Property Administration. Thaum lub Cuaj Hlis 2022, National Intellectual Property Administration tau tshaj tawm cov kev tshawb fawb thawj zaug semaglutide GLP-1 compound patent kom tsis raug kiag li, vim Novo Nordisk "tsis tau nthuav tawm cov ntaub ntawv tshawb fawb ntawm cov ntsiab lus tseem ceeb ntawm semaglutide." Hauv kev teb, Novo Nordisk tau tshaj tawm rau pej xeem tias qhov sib xyaw patent rau semaglutide yuav tas rau xyoo 2026. Cov ntaub ntawv tsis raug cai ntawm cov ntaub ntawv sib xyaw patent rau semaglutide tseem tsis tau txog qhov kawg thiab tseem tab tom sim nyob rau hauv Lub Tsev Hais Plaub Kev Txawj Ntse ntawm Lub Tsev Hais Plaub Siab.

GenoHope Biotech Co., Ltd.
Ib lub tuam txhab ua lag luam ntawm GLP-1 API
Pom zoo los ntawm FDA
Zoo siab txais tos txhua qhov kev nug
WhatsApp / Tel: +8613833133635
Email:info@genohopebio.com